Cancers,
Journal Year:
2020,
Volume and Issue:
12(6), P. 1475 - 1475
Published: June 5, 2020
Treatment
of
advanced
(metastatic)
non-small-cell
lung
cancer
(NSCLC)
is
currently
mainly
based
on
immunotherapy
with
antibodies
against
PD-1
or
PD-L1,
alone,
in
combination
chemotherapy.
In
locally
NSCLC
and
early
resected
stages,
also
employed.
Tumor
PD-L1
expression
by
immunohistochemistry
considered
the
standard
practice.
Response
rate
low,
median
progression
free
survival
very
short
vast
majority
studies
reported.
Herein,
numerous
biological
facets
are
described
involving
driver
genetic
lesions,
mutations
ad
fusions,
glycosylation,
ferroptosis
metabolic
rewiring
adenocarcinoma
(LUAD).
Novel
concepts,
such
as
immune-transmitters
effect
neurotransmitters
immune
evasion
tumor
growth,
nascent
relevance
necroptosis
pyroptosis,
possible
new
biomarkers,
gasdermin
D
E,
conundrum
K-Ras
LUADs,
growing
recognition
liver
kinase
B1
(LKB1)
pathways,
including
others,
commented.
The
review
serves
to
charter
diverse
treatment
solutions,
depending
main
altered
signaling
order
have
effectual
immunotherapy.
PDCD1
gene
(encoding
PD-1)
has
been
recently
described,
equilibrium
(encoded
PDCD1LG1).
Such
description
explains
hyper-progression,
which
reported
several
studies,
poises
fundamental
criterion
that
IHC
a
biomarker
should
be
revisited.
Cancers,
Journal Year:
2019,
Volume and Issue:
11(12), P. 2002 - 2002
Published: Dec. 12, 2019
Janus
kinase-signal
transducer
and
activator
of
transcription
(JAK-STAT)
signaling
mediates
almost
all
immune
regulatory
processes,
including
those
that
are
involved
in
tumor
cell
recognition
tumor-driven
escape.
Antitumor
responses
largely
driven
by
STAT1
STAT2
induction
type
I
II
interferons
(IFNs)
the
downstream
programs
IFNs
potentiate.
Conversely,
STAT3
has
been
widely
linked
to
cancer
survival,
immunosuppression,
sustained
inflammation
microenvironment.
The
discovery
JAK-STAT
cross-regulatory
mechanisms,
post-translational
control,
non-canonical
signal
transduction
added
a
new
level
complexity
governance
over
initiation
progression.
Endeavors
better
understand
vast
effects
on
antitumor
immunity
have
unearthed
wide
range
targets,
oncogenes,
miRNAs,
other
co-regulatory
factors,
which
direct
specific
phenotypical
outcomes
subsequent
stimulation.
Yet,
rapidly
expanding
field
therapeutic
developments
aimed
resolve
aberrations
commonly
reported
multitude
cancers
marred
off-target
effects.
Here,
we
discuss
biology
context
cancer,
consequences
pathway
perturbations
current
interventions,
provide
insight
consideration
for
future
targeting
innovations.
Inflammation and Regeneration,
Journal Year:
2019,
Volume and Issue:
39(1)
Published: June 5, 2019
Interleukin-1,
an
inflammatory
cytokine,
is
considered
to
have
diverse
physiological
functions
and
pathological
significances
play
important
role
in
health
disease.
In
this
decade,
interleukin-1
family
members
been
expanding
evidence
accumulating
that
highlights
the
importance
of
linking
innate
immunity
with
a
broad
spectrum
diseases
beyond
diseases.
review,
we
look
back
on
definition
"inflammation"
traditional
general
pathology
discuss
new
insights
into
view
its
history
molecular
bases
diseases,
as
well
current
progress
therapeutics.
Cancer Research,
Journal Year:
2020,
Volume and Issue:
80(5), P. 1088 - 1101
Published: Jan. 8, 2020
Pancreatic
ductal
adenocarcinoma
(PDA)
is
an
aggressive
malignancy
typified
by
a
highly
stromal
and
weakly
immunogenic
tumor
microenvironment
that
promotes
evolution
contributes
to
therapeutic
resistance.
Here,
we
demonstrate
PDA
cell-derived
proinflammatory
cytokine
IL1β
essential
for
the
establishment
of
protumorigenic
microenvironment.
Tumor
promoted
activation
secretory
phenotype
quiescent
pancreatic
stellate
cells
established
immunosuppressive
milieu
mediated
M2
macrophages,
myeloid-derived
suppressor
cells,
CD1dhiCD5+
regulatory
B
Th17
cells.
Loss
IL1
signaling
in
stroma
enabled
intratumoral
infiltration
CD8+
cytotoxic
T
attenuated
growth
neoplasia,
conferred
survival
advantage
PDA-bearing
mice.
Accordingly,
antibody-mediated
neutralization
significantly
enhanced
antitumor
activity
α-PD-1
was
accompanied
increased
cell
expression
vivo
driven
microbial-dependent
toll-like
receptor
4
(TLR4)
subsequent
engagement
NLRP3
inflammasome.
Collectively,
these
findings
identify
hitherto
unappreciated
role
orchestrating
immune-modulatory
program
supports
tumorigenesis.
SIGNIFICANCE:
These
new
modality
immune
evasion
depends
on
production
through
TLR4-NLRP3
inflammasome
activation.
Targeting
this
axis
might
provide
effective
strategy.
Frontiers in Immunology,
Journal Year:
2019,
Volume and Issue:
10
Published: June 7, 2019
The
IL-1
family
of
cytokines
currently
comprises
seven
ligands
with
pro-inflammatory
activity
(IL-1α
and
IL-1β,
IL-18,
IL-33,
IL-36α,
IL-36β,
IL-36γ)
as
well
two
anti-inflammatory
(IL-37,
IL-38).
These
are
known
to
play
a
key
role
in
modulating
both
the
innate
adaptive
immunes
response,
dysregulation
linked
variety
autoimmune
inflammatory
diseases.
Given
increasing
appreciation
link
between
inflammation
cancer,
several
members
this
pathogenesis
cancer
has
been
extensively
investigated.
In
review,
we
highlight
pro-
anti-tumorigenic
effects
identified
for
almost
all
family,
explore
potential
underlying
mechanisms
accounting
these
divergent
effects.
Such
dual
functions
need
be
carefully
assessed
when
developing
therapeutic
intervention
strategies
targeting
cancer.
Cancers,
Journal Year:
2020,
Volume and Issue:
12(7), P. 1791 - 1791
Published: July 4, 2020
Within
a
tumor,
IL-1β
is
produced
and
secreted
by
various
cell
types,
such
as
immune
cells,
fibroblasts,
or
cancer
cells.
The
IL1B
gene
induced
after
“priming”
of
the
cells
second
signal
required
to
allow
maturation
inflammasome-activated
caspase-1.
then
released
leads
transcription
target
genes
through
its
ligation
with
IL-1R1
on
expression
are
guided
polymorphisms
cellular
context.
In
cancer,
has
pleiotropic
effects
angiogenesis,
proliferation,
migration,
metastasis.
Moreover,
anti-cancer
treatments
able
promote
production
opposite
progression.
This
raises
question
whether
not
use
inhibitors
in
treatment.
Cancers,
Journal Year:
2019,
Volume and Issue:
12(1), P. 37 - 37
Published: Dec. 21, 2019
Non-small-cell
lung
cancer
(NSCLC)
represents
a
heterogeneous
group
of
malignancies
consisting
essentially
adenocarcinoma
(ADC)
and
squamous
cell
carcinoma
(SCC).
Although
the
diagnosis
treatment
ADC
SCC
have
been
greatly
improved
in
recent
decades,
there
is
still
an
urgent
need
to
identify
accurate
transcriptome
profile
associated
with
histological
subtypes
NSCLC.
The
present
study
aims
key
dysregulated
pathways
genes
involved
development
relate
them
clinical
traits.
transcriptional
changes
between
tumour
normal
tissues
were
investigated
by
RNA-seq.
Gene
ontology
(GO),
canonical
analysis
prediction
upstream
regulators,
weighted
gene
co-expression
network
(WGCNA)
co-expressed
modules
hub
used
explore
biological
functions
identified
genes.
It
was
indicated
that
specific
signatures
differed
significantly
related
distinct
pathways.
Of
modules,
four
two
most
features
SCC,
respectively.
CTLA4,
MZB1,
NIP7,
BUB1B
ADC,
as
well
GNG11
CCNB2
are
novel
top
size,
SUVmax,
recurrence-free
survival.
Our
research
provides
more
effective
understanding
importance
relationships
major
NSCLC
perspective
searching
for
new
molecular
targets.
International Journal of Oral Science,
Journal Year:
2020,
Volume and Issue:
12(1)
Published: Jan. 2, 2020
Abstract
Interleukin(IL)-1β,
a
pro-inflammatory
cytokine,
was
elevated
and
participates
in
periodontitis.
Not
only
the
link
between
IL-1β
periodontitis
proved
by
clinical
evidence,
but
also
increased
triggers
series
of
inflammatory
reactions
promotes
bone
resorption.
Currently,
blockage
has
been
therapeutic
strategies
for
autoimmune
autoinflammatory
diseases
such
as
rheumatoid
arthritis,
cryopyrin-associated
periodic
syndromes,
gout
type
II
diabetes
mellitus.
It
is
speculated
that
be
potential
target
The
review
focuses
on
production,
mechanism,
present
treatments
future
Cells,
Journal Year:
2019,
Volume and Issue:
8(7), P. 733 - 733
Published: July 17, 2019
RhoA
is
a
ubiquitously
expressed
cytoplasmic
protein
that
belongs
to
the
family
of
small
GTPases.
acts
as
molecular
switch
activated
in
response
binding
chemokines,
cytokines,
and
growth
factors,
via
mDia
ROCK
signaling
cascade
regulates
activation
cytoskeletal
proteins,
other
factors.
This
review
aims
summarize
our
current
knowledge
on
role
general
key
regulator
immune
cell
differentiation
function.
The
contribution
for
primary
functions
innate
types,
namely
neutrophils,
macrophages,
conventional
dendritic
cells
(DC)
(i)
get
by
pathogen-derived
endogenous
danger
signals,
(ii)
migrate
sites
infection
inflammation,
(iii)
internalize
pathogens
has
been
fairly
established.
In
DC,
which
constitute
most
potent
antigen-presenting
system,
also
important
presentation
antigen
formation
an
immunological
synapse
between
DC
antigen-specific
T
prerequisite
induce
adaptive
responses.
B
effector
system
Rho
pivotal
migration.
More
recently,
mutations
Rho-modulating
factors
have
identified
predispose
autoimmune
diseases
causative
hematopoietic
malignancies.